为博雅干细胞下属分公司AABB指AmericanAssociationofBloodBanking，
为博雅干细胞下属分公司安徽分公司指博雅干细胞科技有限公司安徽分公司，北京大成律师事务所关于宁夏钢丝绳股份有限公司重大资产购买事项之法律意见书时间：西福茂投资管理有
限公司、ChinaTel:8610-Fax:8610- 目录释义·······························································································3一、ParkviewGreen,
车辆及其他设备··················································60（三）知识产权及资质·································································62（四）重大合同··········································································67（五）税务况··········································································70（六）劳动人事··········································································73（七）未决诉讼··········································································74八、标的公司的重大事项··································································52（一）股权投资··········································································52（二）机器设备、万元如无别指称，九龙坡区无地址注册公司国际细胞联合会的简称。即标的公司北京明润北京明润广居投资有限责任公司，关于本次重大资产购买相关人员买卖新日恒力股票的况··············78十二、本次重大资产购买的相关协议及承诺··············································31（一）《重大资产购买协议》························································31（二）《业绩承诺及补偿协议》·····················································35（三）承诺事项··········································································39六、
No.9,博雅干细胞全资子公司北京博雅指北京博雅未名联合干细胞科技有限公司，Fangcaodi, 博雅干细胞控股 子公司湖北分公司指博雅干细胞科技有限公司湖北分公司， 本所指北京大成律师事务所本所律师指北京大成律师事务所为本项目指派的承办律师新日恒力/上市公司/公司指宁夏新日恒力钢丝绳股份有限公司本次交易、DongdaqiaoRoad,本次重大资产购买的批准与授权····················································27（一）已经取得的批准和授权························································27（二）尚需取得的批准和授权························································28四、下列词语具有下列含
义：本次重大资产重组指新日恒力以支付现金的方式收购博雅干细胞科技有限公司80%的股权交易对方指许晓椿、除非文义另有所指，为本次交易的交易对方之一西福茂西福茂投资管理有限公司， 为博雅干细胞下属分公司江苏分公司指博雅干细胞科技有限公司江苏分公司， 美国库协会的简称。本次重大资产购买的实质条件·······················································28（一）本次交易构成重大资产重组··················································28（二）本次交易不构成借壳上市·····················································29（三）本次交易符合《重组管理办法》第十一条的规定······················29（四）本次交易符合《重组规定》第四条之规定································30五、ChaoyangDist.,为博雅干细胞下属分公司浙江分公司指博雅干细胞科技有限公司浙江分公司，标的公司的基本况··································································43（一）标的公司基本信息······························································43（二）历史沿革··········································································44七、系指人民单位《证券法》汽博中心办税务登记证 美国AABB标准是干细胞领域的国际公认的标准之一FACT指FederationfortheAccreditationofCellularTherapy，本次重大资产购买相关事项的信息披露·········································76十一、2015年10月27日22:05:41 中财网北京大成律师事务所关于宁夏新日恒力钢丝绳股份有限公司重大资产购买事项之法律意见书大成证字[2015]第198-1号AdobeSystemswww.dachenglaw.com北京市朝区东大桥路9号侨福芳草地D座7层7/F, 博雅干细胞控股子公司广州中科博雅指广州中科博雅干细胞科技有限公司，该标准是世界卫生组织检测的官方标准元、渝北区办执照博雅干细胞全资子公司江苏博雅再生学指江苏博雅再生学科技有限公司，为本次交易的交易对方之一重庆博雅指重庆英科博雅干细胞科技有限公司，北京大成律师事务所关于宁夏钢丝绳股份有限公司重大资产购买事项之法律意见书-[中财网] [大事件]新日恒力：[大事件]新日恒力：本次重大资产购买涉及的权务的处理······································76十、本次重大资产购买方案的主要内容···················································7二、为本次交易的交易对方之一杭州茂信杭州茂信合利股权投资合伙企业（有限合伙），BuildingD,
杨利娟、博雅干细胞全资子公司广西博雅指广西博雅干细胞科技有限公司，
本次重大资产购买涉及的关联交易及同业竞争··································75（一）关联交易··········································································75（二）同业竞争··········································································75九、FACT标准是国际干细胞临床应用和细胞的标准之一NRL标准指国际外部质量保证系统（EQAS）是由NRL澳洲国家清咨询实验室（NationalSerologyReferenceLaboratory）为了协助临床实验室建立清检验（EIA）及核酸检验（NAT）品质的监控所涉及的一套能力实验，渝中区办执照流程北京明润广居投资有限责任公司、
博雅干细胞全资子公司广东博雅指广东博雅干细胞科技有限公司，
本次重大资产购买相关各方的主体资格···········································14（一）新日恒力的主体资格···························································14（二）交易对方的主体资格···························································23三、
博雅干细胞全资子公司上海钧诣指上海钧诣实业有限公司，本次重大资产购买的中介机构及其资格合法·····························79十三、王建荣标的资产/交易标的指交易对方合计持有的博雅干细胞科技有限公司80%的股权博雅干细胞指博雅干细胞科技有限公司，结论意见············································································79 释义在本法律意见书内， Beijing,博雅干细胞控股子公司江苏博雅指江苏博雅干细胞科技有限公司，本次重大资产购买、
